FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

Report of Foreign Private Issuer 

Pursuant to Rule 13a-16 or 15d-16 

under the Securities Exchange Act of 1934

 

For the month of January, 2022

 

001-14832 

(Commission File Number)

 

 

 

CELESTICA INC. 

(Translation of registrant’s name into English)

 

 

 

5140 Yonge Street, Suite 1900 

Toronto, Ontario 

Canada M2N 6L7 

(416) 448-5800 

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F  x Form 40-F  ¨

 

Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 

Furnished Herewith (and incorporated by reference herein)

 

Exhibit No.   Description
     
99.1   Press Release, dated January 27, 2022

 

The information contained in Exhibit 99.1 of this Form 6-K is not incorporated by reference into any registration statement (or into any prospectus that forms a part thereof) filed by Celestica Inc. with the Securities and Exchange Commission.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    CELESTICA INC.
     
Date:  January 27, 2022 By: /s/ Robert Ellis
    Robert Ellis
    Chief Legal Officer and Corporate Secretary

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
99.1   Press Release, dated January 27, 2022

 

 

 

Exhibit 99.1

 

 

 

FOR IMMEDIATE RELEASE January 27, 2022

 

Celestica Announces 2022 Annual Meeting of Shareholders

 

TORONTO, Canada - Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing and supply chain solutions for the world's most innovative companies, today announced that the Annual Meeting of its Shareholders will be held on Thursday, April 28, 2022 at 9:30 a.m. EDT in a virtual format due to the ongoing public health concerns related to the COVID-19 pandemic.

 

Celestica also announced that it has set Friday, March 11, 2022 as the record date for determining shareholders of the company who are entitled to receive notice of, and to vote at, the meeting. This year, Celestica will be using the notice-and-access method for delivering the company’s proxy statement and related materials to shareholders eligible to participate at the meeting. Shareholders should expect to receive a notice-and-access document in late March. The notice-and-access document will describe the various ways in which shareholders can obtain a copy of the company’s proxy materials. The company’s proxy statement will also be available on the company’s website at www.celestica.com/shareholder-documents and on the company’s profiles on SEDAR at www.sedar.com and EDGAR at www.sec.gov.

 

About Celestica

 

Celestica enables the world's best brands. Through our recognized customer-centric approach, we partner with leading companies in Aerospace and Defense, Communications, Enterprise, HealthTech, Industrial, Capital Equipment, and Energy to deliver solutions for their most complex challenges. As a leader in design, manufacturing, hardware platform and supply chain solutions, Celestica brings global expertise and insight at every stage of product development - from the drawing board to full-scale production and after-market services. With talented teams across North America, Europe and Asia, we imagine, develop and deliver a better future with our customers. For further information on Celestica, visit www.celestica.com. Our securities filings can be accessed at www.sedar.com and www.sec.gov.

 

Contacts:

 

Celestica Global Communications Celestica Investor Relations
(416) 448-2200 (416) 448-2211
media@celestica.com clsir@celestica.com

 

 



The information that you are accessing on this website may include forward-looking statements related to our future growth, trends in our industry, our financial and operational results and performance that are based on current expectations, forecast and assumptions involving risk and uncertainties that could cause actual outcomes and results to differ materially.


Read the full Cautionary Note here